Skip to search.
 FTSE 100 Up 3.08%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
12.35 Up 0.62(5.29%) 12 Feb 21:00
Prev Close:11.73
Open:11.83
Bid:11.45 x 2500
Ask:12.60 x 100
1y Target Est:33.25
Beta:0.887301
Earnings Date:24 Feb - 29 Feb (Est.)
Day's Range:11.30 - 12.44
52wk Range:10.20 - 41.97
Volume:1,160,039
Avg Vol (3m):1,965,680
Market Cap:559.10m
P/E (ttm):N/A
EPS (ttm):-4.83
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SRPTUp 5.29%559.10m
GSKUp 1.56%96.22b
ALNYUp 4.55%5.05b
ISIS 0.00%6.91b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19,667.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-4.88
Quarterly EPS Est (Dec-15) :-1.18
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):12.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback